Keith S. Manchester, a Director and shareholder, reported indirect and direct sales of Roivant Sciences common shares on June 26, June 29 and June 30, 2026. The transactions were executed at prices ranging from $33.92 to $35.45 per share with a weighted average price of $34.44. The total proceeds from the six sales reported were $56,444,075. After the reported transactions, Manchester directly owned 1,748,403 common shares and indirectly owned 13,689,166 common shares (held by QVT Financial Investment Cayman Ltd.).

Reporter NameManchester Keith SRelationshipDirectorTypeSellAmount$56,444,075SEC Filing
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.